Clinical trial
The Role of Circulating Tumour DNA in Head and Neck Cancer
NCT05539638 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Circulating Tumour DNA in Head and Neck Cancer
- Lead sponsor
- University of Edinburgh
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 14, 2022
- Completion date
- August 31, 2027
- Enrollment
- 250 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
human papillomavirus (hpv), oropharyngeal squamous cell carcinoma